Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Annexon, Inc. (ANNX)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 86,097,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Annexon is a clinical-stage biopharmaceutical company developing a class of complement medicines designed to stop the classical complement pathway at its start, C1q, in order to bring therapies to patients suffering from serious complement-mediated autoimmune, neurodegenerative and ophthalmic disorders. Co. is developing a pipeline of product candidates designed to block the activity of C1q and the entire classical complement pathway for a range of complement-mediated diseases. Co.'s pipeline includes three clinical-stage assets across three therapeutic franchises: autoimmune, neurodegenration and ophtamology. Co. its developing its primary candidate, ANX005.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 3,200 353,200 653,200 5,754,246
Total Buy Value $19,411 $1,027,411 $1,667,131 $29,090,439
Total People Bought 1 2 3 3
Total Buy Transactions 1 2 3 5
Total Shares Sold 17,898 59,898 62,990 73,114
Total Sell Value $98,919 $288,851 $300,713 $361,680
Total People Sold 4 4 4 4
Total Sell Transactions 7 9 12 17
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 83
  Page 3 of 4  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Lew Jennifer EVP & Chief Financial Officer   •       –      –    2021-09-13 4 OE $7.49 $26,210 D/D 3,500 5,500     -
   Love Douglas President & CEO   •       •      –    2021-06-08 4 AS $22.55 $84,563 D/D (3,750) 0     -
   Love Douglas President & CEO   •       •      –    2021-06-08 4 OE $1.41 $5,286 D/D 3,750 3,750     -
   Love Douglas President & CEO   •       •      –    2021-06-07 4 AS $22.31 $83,667 D/D (3,750) 0     -
   Love Douglas President & CEO   •       •      –    2021-06-07 4 OE $1.41 $5,286 D/D 3,750 3,750     -
   Yednock Ted EVP & Chief Scientific Officer   •       –      –    2021-06-03 4 AS $21.45 $322,325 D/D (15,000) 0     -
   Yednock Ted EVP & Chief Scientific Officer   •       –      –    2021-06-03 4 OE $1.41 $21,144 D/D 15,000 15,000     -
   Lew Jennifer EVP & Chief Financial Officer   •       –      –    2021-05-27 4 AS $22.24 $77,835 D/D (3,500) 2,000     -
   Lew Jennifer EVP & Chief Financial Officer   •       –      –    2021-05-27 4 OE $7.49 $26,210 D/D 3,500 5,500     -
   Love Douglas President & CEO   •       •      –    2021-04-01 4 AS $28.01 $14,041 D/D (500) 0     -
   Love Douglas President & CEO   •       •      –    2021-04-01 4 OE $1.41 $705 D/D 500 500     -
   Love Douglas President & CEO   •       •      –    2021-03-31 4 AS $28.11 $199,621 D/D (7,102) 0     -
   Love Douglas President & CEO   •       •      –    2021-03-31 4 OE $1.41 $10,011 D/D 7,102 7,102     -
   Love Douglas President & CEO   •       •      –    2021-03-30 4 AS $24.27 $91,966 D/D (3,750) 0     -
   Love Douglas President & CEO   •       •      –    2021-03-30 4 OE $1.41 $5,286 D/D 3,750 3,750     -
   Love Douglas President & CEO   •       •      –    2021-03-29 4 AS $25.02 $95,334 D/D (3,750) 0     -
   Love Douglas President & CEO   •       •      –    2021-03-29 4 OE $1.41 $5,286 D/D 3,750 3,750     -
   Yednock Ted EVP & Chief Scientific Officer   •       –      –    2021-03-25 4 AS $28.54 $465,770 D/D (16,175) 0     -
   Yednock Ted EVP & Chief Scientific Officer   •       –      –    2021-03-25 4 OE $1.41 $27,148 D/D 16,175 16,175     -
   Keswani Sanjay EVP & Chief Medical Officer   •       –      –    2021-03-24 4 AS $30.17 $120,512 D/D (3,995) 0     -
   Keswani Sanjay EVP & Chief Medical Officer   •       –      –    2021-03-24 4 OE $7.49 $29,917 D/D 3,995 3,995     -
   Lew Jennifer EVP & Chief Financial Officer   •       –      –    2021-03-23 4 AS $27.51 $142,176 D/D (5,000) 2,000     -
   Lew Jennifer EVP & Chief Financial Officer   •       –      –    2021-03-23 4 OE $7.49 $37,443 D/D 5,000 7,000     -
   Green Jeremy 10% Owner   –       –       •   2020-07-28 4 A $0.00 $0 I/I 1,596,222 1,596,222     -
   Schwarzman Stephen A 10% Owner   –       –       •   2020-07-28 4 B $17.00 $3,400,000 I/I 200,000 2,730,635 1.5     -
  83 Records found
  1  2  3  4   
  Page 3 of 4
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us